» Articles » PMID: 39641272

Rapid Systemic Spread and Minimal Immune Responses Following SIVsab Intrarectal Transmission in African Green Monkeys

Abstract

African green monkeys (AGMs) are natural hosts of SIV whose infection does not progress to AIDS. Since early events of infection may be critical to pathogenesis in nonnatural hosts, we investigated early SIV infection in 29 adult male AGMs intrarectally inoculated with SIVsab92018 (SIVsab) and serially sacrificed throughout acute into early chronic infection to understand patterns of viral establishment, dissemination, and their effect on disease progression. Using this model, we showed that foci of virus replication could be detected at the site of inoculation and in the draining lymphatics as early as 1-3 days postinfection (dpi). Furthermore, testing with ultrasensitive assays showed rapid onset of viremia (2-4 dpi). After systemic spread, virus was detected in all tissues surveyed. Multiple transmitted/founder viruses were identified, confirming an optimal challenge dose, while demonstrating a moderate mucosal genetic bottleneck. Resident CD4+ T cells were the initial target cells; other immune cell populations were not significantly altered at the site of entry. Thus, intrarectal SIVsab infection is characterized by swift dissemination of the virus, a lack of major target cell recruitment, and no window of opportunity for interventions to prevent virus dissemination during the earliest stages of infection, similar to intrarectal transmission but different from vaginal transmission in macaques.

Citing Articles

It's all in the gut: the central role of the gut and microbiome in preventing disease progression in simian immunodeficiency viruses infected African nonhuman primates.

Raehtz K, Pandrea I, Apetrei C Curr Opin HIV AIDS. 2025; 20(2):124-132.

PMID: 39774258 PMC: 11802300. DOI: 10.1097/COH.0000000000000911.

References
1.
Cillo A, Vagratian D, Bedison M, Anderson E, Kearney M, Fyne E . Improved single-copy assays for quantification of persistent HIV-1 viremia in patients on suppressive antiretroviral therapy. J Clin Microbiol. 2014; 52(11):3944-51. PMC: 4313209. DOI: 10.1128/JCM.02060-14. View

2.
Parker Z, Iyer S, Wilen C, Parrish N, Chikere K, Lee F . Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. J Virol. 2012; 87(5):2401-11. PMC: 3571396. DOI: 10.1128/JVI.02964-12. View

3.
Chen Z, Gettie A, Ho D, Marx P . Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology. 1998; 246(1):113-24. DOI: 10.1006/viro.1998.9174. View

4.
Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser W, Garber D . Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol. 2005; 79(7):4043-54. PMC: 1061583. DOI: 10.1128/JVI.79.7.4043-4054.2005. View

5.
Mankowski J, Clements J, Zink M . Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis. 2002; 186 Suppl 2:S199-208. DOI: 10.1086/344938. View